Overview
Natasa Dragasevic-Miskovic practices in Belgrade, Serbia. Ms. Dragasevic-Miskovic is highly rated in 4 conditions, according to our data. Her top areas of expertise are Acute Cerebellar Ataxia, Drug Induced Dyskinesia, Movement Disorders, and Parkinson's Disease.
Her clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Cerebellar AtaxiaMs. Dragasevic-Miskovic isAdvanced. Learn about Acute Cerebellar Ataxia.
- Drug Induced DyskinesiaMs. Dragasevic-Miskovic isAdvanced. Learn about Drug Induced Dyskinesia.
- Movement DisordersMs. Dragasevic-Miskovic isAdvanced. Learn about Movement Disorders.
- Parkinson's DiseaseMs. Dragasevic-Miskovic isAdvanced. Learn about Parkinson's Disease.
- Experienced
- Brown SyndromeMs. Dragasevic-Miskovic isExperienced. Learn about Brown Syndrome.
- DysarthriaMs. Dragasevic-Miskovic isExperienced. Learn about Dysarthria.
- Familial DysautonomiaMs. Dragasevic-Miskovic isExperienced. Learn about Familial Dysautonomia.
- Focal DystoniaMs. Dragasevic-Miskovic isExperienced. Learn about Focal Dystonia.
- Hepatocerebral DegenerationMs. Dragasevic-Miskovic isExperienced. Learn about Hepatocerebral Degeneration.
- Neurotoxicity SyndromesMs. Dragasevic-Miskovic isExperienced. Learn about Neurotoxicity Syndromes.